Key facts
- This page summarizes Jonathan Siegal's Form 4 filing for Vericel Corp (VCEL).
- 6 reported transactions and 2 derivative rows are listed below.
- Accepted by SEC: 26 Feb 2026, 16:05.
Key filing fact
Ownership activity is grounded in SEC Form 4 disclosures.
Shares, units, or other non-derivative securities reported in this filing.
Options Exercise
Tax liability
Options Exercise
Tax liability
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
Options Exercise
Options Exercise
Additional SEC filing notes
Footnote F1
The shares of common stock were acquired by the Reporting Person as a result of the vesting of Restricted Stock Units (RSUs) granted to the Reporting Person on February 20, 2025. The remaining RSUs will vest in annual installments on February 20, 2027, February 20, 2028, and February 20, 2029, respectively.
Footnote F2
These shares include shares acquired pursuant to the Issuer's 2015 Employee Stock Purchase Plan in transactions that were exempt under both Rule 16b-3(d) and Rule 16b-3(c).
Footnote F3
These shares were withheld by the Issuer to satisfy the tax withholding requirements in connection with the vesting of RSUs.
Footnote F4
The shares of common stock were acquired by the Reporting Person as a result of the vesting of RSUs granted to the Reporting Person on February 22, 2024. The remaining RSUs will vest in annual installments on February 22, 2027, and February 22, 2028, respectively.
Footnote F5
Each RSU represents a contingent right to receive one share of common stock of Vericel Corporation.
Footnote F6
No expiration date for this type of award.
Footnote F7
The Fair Market Value of the vested derivative securities is $38.09 per share.
Footnote F8
The Fair Market Value of the vested derivative securities is $38.25 per share.